Betashares Nasdaq 100 Equal Weight Etf fund (ASX:QNDQ)
Australia · Delayed Price · Currency is AUD 16.17
+0.24 (1.51%)
Last updated: Apr 17, 2026, 11:23 AM AEST
11.59% (1Y)
| Assets | n/a |
| Expense Ratio | 0.48% |
| PE Ratio | 27.00 |
| Dividend (ttm) | 0.28 |
| Dividend Yield | 1.71% |
| Ex-Dividend Date | Jan 2, 2026 |
| Payout Frequency | Semi-Annual |
| Payout Ratio | 46.04% |
| 1-Year Return | +13.46% |
| Volume | 731 |
| Open | 16.17 |
| Previous Close | 15.93 |
| Day's Range | 16.16 - 16.17 |
| 52-Week Low | 14.44 |
| 52-Week High | 17.66 |
| Beta | 0.05 |
| Holdings | 10 |
| Inception Date | Feb 20, 2024 |
About QNDQ
QNDQ.AX was created on 2024-02-20 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. QNDQ.AX aims to track the performance of the Nasdaq-100 Equal Weighted Index (before fees and expenses).
Asset Class Equity
Category Large Cap
Stock Exchange Australian Securities Exchange
Ticker Symbol QNDQ
Provider BetaShares
Index Tracked NASDAQ-100 Equally Weighted Index
Performance
QNDQ had a total return of 13.46% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.49%.
Top Holdings
10.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Insmed Incorporated | INSM | 1.20% |
| Arm Holdings plc | ARM | 1.14% |
| Marvell Technology, Inc. | MRVL | 1.12% |
| CSX Corporation | CSX | 1.08% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 1.08% |
| Regeneron Pharmaceuticals, Inc. | REGN | 1.07% |
| PDD Holdings Inc. | PDD | 1.07% |
| Netflix, Inc. | NFLX | 1.07% |
| O'Reilly Automotive, Inc. | ORLY | 1.06% |
| Fastenal Company | FAST | 1.06% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jan 2, 2026 | 0.02358 AUD | Jan 19, 2026 |
| Jul 1, 2025 | 0.25214 AUD | Jul 16, 2025 |
| Jan 2, 2025 | 0.0124 AUD | Jan 17, 2025 |
| Jul 1, 2024 | 0.24535 AUD | Jul 16, 2024 |